Gwenaelle De Clifford-Faugère, Hermine Lore Nguena Nguefack, Nancy Ménard, Sylvie Beaudoin, M Gabrielle Pagé, Line Guénette, Catherine Hudon, Oumar Mallé Samb, Anaïs Lacasse
{"title":"在魁北克省慢性疼痛患者中,解包装过度的多种药物模式:一项纵向研究。","authors":"Gwenaelle De Clifford-Faugère, Hermine Lore Nguena Nguefack, Nancy Ménard, Sylvie Beaudoin, M Gabrielle Pagé, Line Guénette, Catherine Hudon, Oumar Mallé Samb, Anaïs Lacasse","doi":"10.3389/fpain.2025.1512878","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Excessive polypharmacy, which can be defined as the concurrent use of ≥10 medications, is prevalent among individuals with chronic pain. However, it remains unclear how it may vary between individuals or over time.</p><p><strong>Objectives: </strong>This study aimed to describe and identify factors associated with trajectories of excessive polypharmacy.</p><p><strong>Methods: </strong>A retrospective longitudinal study was conducted using the TorSaDE Cohort, which links Canadian Community Health Surveys (2007-2016) and Quebec health administrative databases. Among 9,156 adults living with chronic pain and covered by public prescribed drug insurance, the presence of excessive polypharmacy (yes/no) was assessed monthly for one-year post-survey completion (12 time points). Group-based trajectory modelling was applied to identify groups with similar patterns over time (trajectories). Multivariable multinomial regression was used to identify factors associated with trajectory membership.</p><p><strong>Results: </strong>Four trajectories were obtained: (1) \"No excessive polypharmacy\" (74.8%); (2) \"Sometimes in excessive polypharmacy\" (8.6%); (3) \"Often in excessive polypharmacy\" (6.1%); 4) \"Always in excessive polypharmacy\" (10.5%). Factors associated with the \"always in excessive polypharmacy\" trajectory membership were: being older, being born in Canada, having a lower income, having a higher comorbidity index score, more severe pain intensity, and more daily activities prevented by pain, reporting arthritis or back pain and poorer perceived general health, and having a family physician. Using opioids or benzodiazepines, having a lower alcohol consumption, doing less physical activity, a higher number of prescribers and visits to a family physician also predicted being always in excessive polypharmacy.</p><p><strong>Discussion: </strong>This study identifies distinct trajectories of excessive polypharmacy in adults with chronic pain, emphasizing key sociodemographic and clinical factors and the need for tailored interventions for effective medication management.</p>","PeriodicalId":73097,"journal":{"name":"Frontiers in pain research (Lausanne, Switzerland)","volume":"6 ","pages":"1512878"},"PeriodicalIF":2.5000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11885514/pdf/","citationCount":"0","resultStr":"{\"title\":\"Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study.\",\"authors\":\"Gwenaelle De Clifford-Faugère, Hermine Lore Nguena Nguefack, Nancy Ménard, Sylvie Beaudoin, M Gabrielle Pagé, Line Guénette, Catherine Hudon, Oumar Mallé Samb, Anaïs Lacasse\",\"doi\":\"10.3389/fpain.2025.1512878\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Excessive polypharmacy, which can be defined as the concurrent use of ≥10 medications, is prevalent among individuals with chronic pain. However, it remains unclear how it may vary between individuals or over time.</p><p><strong>Objectives: </strong>This study aimed to describe and identify factors associated with trajectories of excessive polypharmacy.</p><p><strong>Methods: </strong>A retrospective longitudinal study was conducted using the TorSaDE Cohort, which links Canadian Community Health Surveys (2007-2016) and Quebec health administrative databases. Among 9,156 adults living with chronic pain and covered by public prescribed drug insurance, the presence of excessive polypharmacy (yes/no) was assessed monthly for one-year post-survey completion (12 time points). Group-based trajectory modelling was applied to identify groups with similar patterns over time (trajectories). Multivariable multinomial regression was used to identify factors associated with trajectory membership.</p><p><strong>Results: </strong>Four trajectories were obtained: (1) \\\"No excessive polypharmacy\\\" (74.8%); (2) \\\"Sometimes in excessive polypharmacy\\\" (8.6%); (3) \\\"Often in excessive polypharmacy\\\" (6.1%); 4) \\\"Always in excessive polypharmacy\\\" (10.5%). Factors associated with the \\\"always in excessive polypharmacy\\\" trajectory membership were: being older, being born in Canada, having a lower income, having a higher comorbidity index score, more severe pain intensity, and more daily activities prevented by pain, reporting arthritis or back pain and poorer perceived general health, and having a family physician. Using opioids or benzodiazepines, having a lower alcohol consumption, doing less physical activity, a higher number of prescribers and visits to a family physician also predicted being always in excessive polypharmacy.</p><p><strong>Discussion: </strong>This study identifies distinct trajectories of excessive polypharmacy in adults with chronic pain, emphasizing key sociodemographic and clinical factors and the need for tailored interventions for effective medication management.</p>\",\"PeriodicalId\":73097,\"journal\":{\"name\":\"Frontiers in pain research (Lausanne, Switzerland)\",\"volume\":\"6 \",\"pages\":\"1512878\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11885514/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in pain research (Lausanne, Switzerland)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fpain.2025.1512878\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in pain research (Lausanne, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fpain.2025.1512878","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study.
Introduction: Excessive polypharmacy, which can be defined as the concurrent use of ≥10 medications, is prevalent among individuals with chronic pain. However, it remains unclear how it may vary between individuals or over time.
Objectives: This study aimed to describe and identify factors associated with trajectories of excessive polypharmacy.
Methods: A retrospective longitudinal study was conducted using the TorSaDE Cohort, which links Canadian Community Health Surveys (2007-2016) and Quebec health administrative databases. Among 9,156 adults living with chronic pain and covered by public prescribed drug insurance, the presence of excessive polypharmacy (yes/no) was assessed monthly for one-year post-survey completion (12 time points). Group-based trajectory modelling was applied to identify groups with similar patterns over time (trajectories). Multivariable multinomial regression was used to identify factors associated with trajectory membership.
Results: Four trajectories were obtained: (1) "No excessive polypharmacy" (74.8%); (2) "Sometimes in excessive polypharmacy" (8.6%); (3) "Often in excessive polypharmacy" (6.1%); 4) "Always in excessive polypharmacy" (10.5%). Factors associated with the "always in excessive polypharmacy" trajectory membership were: being older, being born in Canada, having a lower income, having a higher comorbidity index score, more severe pain intensity, and more daily activities prevented by pain, reporting arthritis or back pain and poorer perceived general health, and having a family physician. Using opioids or benzodiazepines, having a lower alcohol consumption, doing less physical activity, a higher number of prescribers and visits to a family physician also predicted being always in excessive polypharmacy.
Discussion: This study identifies distinct trajectories of excessive polypharmacy in adults with chronic pain, emphasizing key sociodemographic and clinical factors and the need for tailored interventions for effective medication management.